Baird Medical Sponsors MGH Thyroid and Parathyroid Surgery Course
Baird Medical (NASDAQ: BDMD) sponsored the Surgery of the Thyroid and Parathyroid Glands Course at Massachusetts General Hospital. The event featured discussions on thyroid and parathyroid surgery advancements, with Dr. Shuhang Xu presenting on microwave ablation (MWA) technology for treating thyroid conditions. The presentation highlighted MWA's benefits, including minimally invasive approach, shorter procedures, and precise ablation capabilities. The course covered upcoming American Thyroid Association guidelines and innovations in thyroid cancer management.
Baird Medical (NASDAQ: BDMD) ha sponsorizzato il Corso di Chirurgia delle Ghiandole Tiroidee e Paratiroidee presso il Massachusetts General Hospital. L'evento ha incluso discussioni sui progressi nella chirurgia tiroidea e paratiroidea, con il Dr. Shuhang Xu che ha presentato la tecnologia di ablazione a microonde (MWA) per il trattamento delle condizioni tiroidee. La presentazione ha messo in evidenza i vantaggi della MWA, tra cui un approccio minimamente invasivo, procedure più brevi e capacità di ablazione precisa. Il corso ha trattato le imminenti linee guida della American Thyroid Association e le innovazioni nella gestione del cancro tiroideo.
Baird Medical (NASDAQ: BDMD) patrocinó el Curso de Cirugía de las Glándulas Tiroides y Paratiroides en el Massachusetts General Hospital. El evento contó con discusiones sobre los avances en la cirugía de tiroides y paratiroides, con el Dr. Shuhang Xu presentando la tecnología de ablación por microondas (MWA) para tratar condiciones tiroideas. La presentación destacó los beneficios de MWA, que incluyen un enfoque mínimamente invasivo, procedimientos más cortos y capacidades de ablación precisas. El curso cubrió las próximas directrices de la American Thyroid Association y las innovaciones en la gestión del cáncer de tiroides.
Baird Medical (NASDAQ: BDMD)은 매사추세츠 종합병원에서 갑상선 및 부갑상선 수술 과정을 후원했습니다. 이 행사에서는 갑상선 및 부갑상선 수술의 발전에 대한 토론이 진행되었으며, Dr. Shuhang Xu가 갑상선 질환 치료를 위한 마이크로웨이브 절제술 (MWA) 기술에 대해 발표했습니다. 발표에서는 MWA의 장점, 즉 최소 침습적 접근, 더 짧은 절차 및 정확한 절제 능력이 강조되었습니다. 이 과정에서는 미국 갑상선 협회의 새로운 지침과 갑상선 암 관리의 혁신에 대해서도 다루었습니다.
Baird Medical (NASDAQ: BDMD) a parrainé le Cours de Chirurgie des Glandes Thyroïdiennes et Parathyroïdiennes à l'Hôpital Général du Massachusetts. L'événement a présenté des discussions sur les avancées en matière de chirurgie thyroïdienne et parathyroïdienne, avec le Dr Shuhang Xu présentant la technologie d'ablation par micro-ondes (MWA) pour le traitement des affections de la thyroïde. La présentation a souligné les avantages de la MWA, notamment une approche peu invasive, des procédures plus courtes et des capacités d'ablation précises. Le cours a également couvert les futures directives de l'American Thyroid Association et les innovations dans la gestion du cancer de la thyroïde.
Baird Medical (NASDAQ: BDMD) hat den Kurs zur Chirurgie der Schilddrüsen und Nebenschilddrüsen am Massachusetts General Hospital gesponsert. Die Veranstaltung beinhaltete Diskussionen über Fortschritte in der Schilddrüsen- und Nebenschilddrüsenchirurgie, wobei Dr. Shuhang Xu über die Mikrowellenablation (MWA)-Technologie zur Behandlung von Schilddrüsenerkrankungen referierte. Die Präsentation hob die Vorteile von MWA hervor, einschließlich eines minimalinvasiven Ansatzes, kürzerer Verfahren und präziser Ablationsfähigkeiten. Der Kurs behandelte die bevorstehenden Richtlinien der American Thyroid Association und Innovationen im Schilddrüsenkrebsmanagement.
- None.
- None.
A key highlight of the event was a panel debate on thermal ablation technologies, where Dr. Shuhang Xu presented on MWA as a promising option for treating thyroid nodules and cancer. His presentation emphasized the advantages of MWA, including its minimally invasive approach, shorter procedure times, and precise ablation capabilities, reflecting its growing adoption in modern thyroid care.
The course also explored updates to the forthcoming American Thyroid Association (ATA) guidelines, advancements in advanced thyroid cancer management, and a range of surgical innovations shaping the field.
By sponsoring this event, Baird Medical reaffirms its dedication to advancing education and collaboration within the medical community. As a pioneer in thermal ablation technology, Baird Medical remains committed to supporting healthcare professionals with innovative solutions for thyroid and parathyroid treatment.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsors-mgh-thyroid-and-parathyroid-surgery-course-302308047.html
SOURCE BDMD
FAQ
What was the main focus of Baird Medical's (BDMD) sponsored course at MGH in November 2024?
What are the key benefits of microwave ablation technology presented by Baird Medical (BDMD) at the MGH course?
Where and when did Baird Medical (BDMD) sponsor the thyroid surgery course?
